DMSO (~33 mg/ml) or EtOH (~ 1.7 mg/ml)
Cell-permeable. A highly potent and selective PARP-inhibitor with ICvalues of 5 nM and 1 nM for PARP-1 and PARP-2, respectively. Olaparib displays standalone activity in BRCA-1 deficient breast cancer cells.
Research or further manufacturing use only, not for food or drug use.